200.47MUSD
2.16
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4884452065
CUSIP
488445107
Sector
Healthcare
Industry
Pharmaceuticals
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.72
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-0.91
Wall Street Target Price
22.33
EPS Estimate Current Year
-1.10
EPS Estimate Next Year
-0.68
EPS Estimate Current Quarter
-0.17
EPS Estimate Next Quarter
-0.15
Most Recent Quarter
-
Revenue TTM
10,721,000
Gross Profit TTM
26,591,000
EBITDA
-17,723,000
Profit Margin
0.00%
Return On Assets TTM
-8.97%
Return On Equity TTM
-31.24%
Revenue Per Share TTM
0.309
Qtly Revenue Growth YOY
46.30%
Diluted Eps TTM
-0.91
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
263
Price Sales TTM
14.1611
Price Book MRQ
1.6922
Enterprise Value Revenue
9
Enterprise Value EBITDA
-2
164.51
9.27%79.75
0.75%99.40
0.28%434.32
0.08%208.35
0.00%26.31
-1.63%20.70
-1.45%588.00
-1.44%65.94
-0.44%228.74
-0.07%